Search Results - "Herme, Maua"

An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone by Vagenas, Panagiotis, Ph.D., M.P.H, Di Paola, Angela, M.S, Herme, Maua, M.P.H, Lincoln, Thomas, M.D, Skiest, Daniel J., M.D, Altice, Frederick L., M.D., M.A, Springer, Sandra A., M.D

“…Abstract Extended-release naltrexone (XR-NTX), an approved treatment for opioid or alcohol dependence, is a once-monthly injectable formulation of naltrexone…”
Get full text

Understanding the Revolving Door: Individual and Structural-Level Predictors of Recidivism Among Individuals with HIV Leaving Jail by Fu, Jeannia J., Herme, Maua, Wickersham, Jeffrey A., Zelenev, Alexei, Althoff, Amy, Zaller, Nickolas D., Bazazi, Alexander R., Avery, Ann K., Porterfield, Jeff, Jordan, Alison O., Simon-Levine, Dominique, Lyman, Martha, Altice, Frederick L.

“…Incarceration, particularly when recurrent, can significantly compromise the health of individuals living with HIV. Despite this, the occurrence of recidivism…”
Get full text

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community by Springer, Sandra A, Altice, Frederick L, Herme, Maua, Di Paola, Angela

“…Abstract Background HIV-infected prisoners have a high prevalence of alcohol use disorders and commonly relapse to alcohol soon after release to the community…”
Get full text

Corrigendum to “Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community” [Contemp. Clin. Trials (2014) 209–218] by Springer, Sandra A, Altice, Frederick L, Herme, Maua, Di Paola, Angela

Get full text

Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community — A potential conduit to improved HIV treatment outcomes by Saber-Tehrani, Ali Shabahang, Springer, Sandra A, Qiu, Jingjun, Herme, Maua, Wickersham, Jeffrey, Altice, Frederick L

“…Abstract Background HIV-infected prisoners experience poor HIV treatment outcomes post-release. Directly administered antiretroviral therapy (DAART) is a…”
Get full text

Comparison of Tuberculin Skin Testing Reactivity in Opioid-Dependent Patients Seeking Treatment with Methadone versus Buprenorphine: Policy Implications for Tuberculosis Screening by Schwarz, Ryan K., Bruce, R. Douglas, Ball, Samuel A., Herme, Maua, Altice, Frederick L.

“…Background: Buprenorphine's availability in primary care settings offers increased access to treatment and linkage to primary care for opioid-dependent…”
Get full text

Corrigendum to ‘An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone’ [Journal of Substance Abuse Treatment 47 (2014) 35–40] by Vagenas, Panagiotis, Di Paola, Angela, Herme, Maua, Lincoln, Thomas, Skiest, Daniel J, Altice, Frederick L, Springer, Sandra A

Get full text